intestinal polyps
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Aged between 45 and 75 years; 2.Continuous subjects undergoing colonoscopy in our center; 3.Use 3-4 L laxatives, defoaming agent, and adjuvant for intestinal preparation according to the guidelines; 4.Signing the Informed Consent.
Exclusion criteria
Exclusion criteria: 1.Patients with highly suspected inflammatory bowel disease, colon cancer, or colon polyposis; 2.People with a history of inflammatory bowel disease, colon cancer, or colon polyps; 3.Tumor subjects who have previously undergone colonoscopy, colon surgery, other colorectal examinations (including surgical polypectomy, mucosectomy, mucosal dissection, etc.) or who are undergoing radiotherapy or chemotherapy; 4.Those who cannot tolerate intestinal preparation or have contraindication to biopsy; 5.Patients taking antiplatelet drugs such as aspirin, clopidogrel, prapogrel, ticagrelor, anticoagulants such as warfarin and heparin, direct oral anticoagulants such as dabigatrun, rivaroxaban, apixaban and edoxaban, failing to discontinue medication, or existing coagulation disorders (platelet count = 1.5); 6.A history of acute myocardial infarction (within 6 months);Have mental illness or symptoms that may make it difficult to participate in the trial;Active bacterial or fungal infection;Poor control of hypertension;Respiratory diseases requiring continuous oxygen treatment;Dialysis; Patients with other serious heart, lung, liver or renal insufficiency diseases or grade IV of American College of Anesthesiologists; 7.Pregnancy or breastfeeding; 8.The total score of the intestinal preparation Boston scale was < 6.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| adenoma detection rate (ADR); | — |
Secondary
| Measure | Time frame |
|---|---|
| polyp detection rate (PDR); | — |
Countries
China
Contacts
Drum Tower Hospital affiliated to Nanjing University Medical School